Patents by Inventor Yvette Weinrauch

Yvette Weinrauch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of bacterial infection with elastase
    Publication number: 20050069532
    Abstract: The present invention relates to methods of treating bacterial infection in a subject, degrading bacterial virulence factors, preventing bacteria from escaping phagosomes of neutrophils, and preventing bacteria from invading host cells, by use of an elastase.
    Type: Application
    Filed: January 29, 2003
    Publication date: March 31, 2005
    Inventors: Yvette Weinrauch, Arturo Zychlinsky
  • Type II phospholipase A2 and its use in killing Gram-positive bacteria
    Patent number: 6280726
    Abstract: Disclosed herein are methods for killing Gram-positive bacterial infections in animals comprising exposing the bacteria to Gram-positive bactericidal-effective amounts of Type II phospholipase A2. The Type II phospholipase A2 can be isolated from mammalian species including humans, cows, rabbits, rats, mice, cats, and dogs. Type II phospholipase A2 is effective in treating infections in mammals, including humans, caused by gram-positive bacteria such as Staphylococcus aureus. Also disclosed are pharmaceutical formulations for use in the methods.
    Type: Grant
    Filed: January 19, 1999
    Date of Patent: August 28, 2001
    Assignee: New York University
    Inventors: Yvette Weinrauch, Peter Elsbach, Jerrold Weiss
  • Method for killing gram positive bacteria with isolated type II phospholipase A2
    Patent number: 5874079
    Abstract: Disclosed herein are methods for killing Gram-positive bacterial infections in animals comprising exposing the bacteria to Gram-positive bactericidal-effective amounts of Type II phospholipase A2. The Type II phospholipase A2 can be isolated from mammalian species including humans, cows, rabbits, rats, mice, cats, and dogs. Type II phospholipase A2 is effective in treating infections in mammals, including humans, caused by gram-positive bacteria such as Staphylococcus aureus. Also disclosed are pharmaceutical formulations for use in the methods.
    Type: Grant
    Filed: July 19, 1996
    Date of Patent: February 23, 1999
    Assignee: New York, University
    Inventors: Yvette Weinrauch, Peter Elsbach, Jerrold Weiss